Bristol-Myers Squibb – Update to recall of Eliquis® (apixaban)
June 17, 2017 – The FDA announced that the recall of one lot of Bristol-Myers Squibb's Eliquis (apixaban) 5 mg tablets has been de-escalated from a consumer-level to a retail/dispensing-level recall.
Download PDF
